Physeon GmbH Names Patrick Kullmann Chief Executive Officer


Physeon GmbH, a leading developer of medical technology products for venous access, announced that the Company has named Mr. Patrick Kullmann as its new Chief Executive Officer.

Patrick Kullmann is an accomplished and experienced senior leader in the MedTech, Bio Tech and Pharmaceutical industries. He has served in numerous leadership positions at large, multinational companies including Johnson and Johnson (JNJ), Boston Scientific (BSX) and Medtronic (MDT). Patrick is also a highly qualified and accomplished leader in the startup space with a proven track record of success in the medical technology field. Physeon is his seventh start up in his 33 years career. Most recently, Patrick served as the COO and President for Medovex Corp. (MDVX) on the NASDAQ and OTC markets. He has successfully raised funding in private and public markets.

"We're very pleased to have Patrick join the Physeon team at such an exciting time in its evolution. Patrick’s background, experience and accomplishments makes him a perfect leader for the organization,” stated Mr. Alan Wilson, CEO of Novintum Medical Technology GmbH, the parent company of Physeon.


NEWSROOM

The Veinplicity device is CE marked and registered as a Class IIa medical device in the European Union and as a Class II medical device in Canada. We are seeking FDA approval. The device is manufactured within the ISO 13485 standard in the United States.

Featured Posts
Follow Veinplicity
Archive
Categories

CONTACT

 

E: info@physeon.com
T: +41 52 630 70 80

ADDRESS

 

Physeon GmbH

Herrenacker 15

8200 Schaffhausen

Switzerland

© 2017 Novintum Medical Technology